ACTRN12612000925842
Completed
未知
A pilot study of a multicomponent non-pharmacological intervention to reduce breathlessness and associated symptoms in people with lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Queensland University of Technology
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosed with a primary or secondary lung cancer; life expectancy of at least 3 months; completed first line therapy;
- •have an average dyspnoea rating \> 2 on an 11 point numeric rating scale in the past week
Exclusion Criteria
- •\< 18 years; have an intellectual or mental impairment; primary language other than English
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Self management and support programme (EDGE) for COPDChronic obstructive pulmonary disease.RespiratoryChronic obstructive pulmonary disease, unspecifiedISRCTN40367841Oxford University (UK)295
Completed
Not Applicable
A prospective clinical trial of a multidisciplinary electronic cardiovascular prevention programmePrevention of Cardiovascular diseasesCirculatory SystemCardiovascular diseasesISRCTN23940498De Onderlinge Ziekenkas (Belgium)350
Recruiting
Not Applicable
Pilot study of multimodality treatment based on a new risk stratification in patients with medulloblastomaJPRN-UMIN000014488Japanese Pediatric Brain Tumor Consortium30
Active, not recruiting
Phase 1
A multi-stage clinical study to develop a non-invasive Short Synacthen Test (SST) with nasally administered synacthen and salivary cortisol. The validated non-invasive SST will be used to establish normative data in children and to detect adrenal suppression in asthmatic children. - The development of a non-invasive Short Synacthen Test - NeSST StudyIn stages 1+2 of the study healthy volunteers will be used to determine the bioequivalence of nasal synacthen with 1 microgram of intravenous synacthen. Stage 3 will use healthy children to establish normal ranges for the adrenal response to a low-dose synacthen test. In stage 4 adrenal function in asthmatic individuals on inhaled corticosteroids will be studied.MedDRA version: 9.0Level: PTClassification code 10001367Term: Adrenal InsufficiencyMedDRA version: 9.0Level: PTClassification code 10006482Term: BronchospasmEUCTR2009-013355-29-GBSheffield Children's NHS Foundation Hospital258
Terminated
Not Applicable
The MultICath StudyTopic: Primary Care, RenalSubtopic: Primary Care (Renal Disorders), Renal (Renal Disorders)Disease: All Diseases, All Renal DisordersUrological and Genital DiseasesCatheterisationISRCTN68472863niversity of Southampton500